NDTV Profit on MSN

Oil, Gas Block Auction Bid Round Deadline Extended For Third Time

The deadline for submission of bids under the fourth round of Discovered Small Field (DSF) bid round and the special coal-bed ...

Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta

Ultragenyx is developing setrusumab in pediatric and young adult patients across OI sub-types I, III and IV with two late-stage studies: the pivotal Phase 2/3 Orbit study and Phase 3 Cosmic study.